[PDF] Top 20 Efectividad de la terapia cuádruple comparada con la triple en el tratamiento de Helicobacter pylori
Has 10000 "Efectividad de la terapia cuádruple comparada con la triple en el tratamiento de Helicobacter pylori" found on our website. Below are the top 20 most common "Efectividad de la terapia cuádruple comparada con la triple en el tratamiento de Helicobacter pylori".
A review of soft-tissue sarcomas: translation of biological advances into treatment measures
... Chemotherapeutics for LPS: eribulin and trabectedin In 2015 and 2016, the FDA approved two chemothera- peutic agents specifically for LPS treatment: eribulin and trabectedin. Eribulin acts by inhibiting the ... See full document
5
Advances in the treatment of soft tissue sarcoma: focus on eribulin
... the treatment of metastatic breast cancer and more recently for non-operable or metastatic liposarcoma in patients who have received prior anthracycline ...the treatment of soft tissue ... See full document
69
Pazopanib in the management of advanced soft tissue sarcomas
... advanced soft tissue ...HRQoL measures are unaffected. The utility of the drug in soft tissue sarcoma management may be further improved by detailed correlative studies to identify the ... See full document
6
New drugs and combinations for the treatment of soft-tissue sarcoma: a review
... Abstract: Sarcomas are a heterogeneous group of solid tumors arising from either soft tissues or bone, accounting for approximately 1% of all cancers in ...of treatment of gastrointestinal stromal ... See full document
21
Review Article Molecular classification of soft tissue sarcomas and its clinical applications
... Abstract: Sarcomas are a heterogeneous group of tumors that are traditionally classified according to the morphology and type of tissue that they resemble, such as rhabdomyosarcoma, which resembles skeletal ... See full document
142
A review of mechanism of actions of ultrasound waves for treatment of soft tissue injuries
... recent advances in applications of US waves for the treatment of wounds and their mechanisms of action and biological interactions with living ... See full document
123
Pulmonary tumor embolism secondary to soft tissue and bone sarcomas: a case report and literature review
... embolectomy was the most commonly utilized therapeutic strategy in this series without the absolute requirement for cardiopulmonary bypass [29, 31]. Additional measures for TE management involve pulmonary ... See full document
47
Systemic Treatment for Adults with Synovial Sarcoma.
... The results of the Alliance A091401 study with the the PD1-inhibitor nivolumab and the combination of nivolumab and the CTLA4-inhibitor ipilimumab tested in 85 STS patients, included 4 SS patients. Objective re- sponses ... See full document
30
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study.
... receiving treatment in the fourth line and fifth line and beyond setting still experienced a clinical benefit with ...in treatment patterns for first-line compared to second and later lines of ...first-line ... See full document
79
Intraabdominal and retroperitoneal soft tissue sarcomas outcome of surgical treatment in primary and recurrent tumors
... primary sarcomas, resection of adjacent organs was necessary in 48%, which is in the same order of magni- tude as in other reports [7], and radical surgery was achieved in 78%, also comparable to other centers ... See full document
81
Original Article Combined chemotherapy and 125 I-particle implantation for treatment of children with head and neck soft tissue sarcomas improve the short-term efficacy: Beijing Children’s Hospital experience over 2 years
... Between 2012 and 2014, 14 patients with head and neck sarcomas were treat- ed in our center. Age at diagnosis ranged between 1.0-10.7 years, and the median age is 4.9 year. There were 12 males and 2 female ... See full document
183
Correlation of Radiologic and Pathologic Response in Patients Receiving Neoadjuvant Radiotherapy for Soft Tissue Sarcoma
... Soft tissue sarcomas are exceedingly rare tumors that account for 1% of all human malignancies. More than 50 histologic subtypes of STS are recognized. Limb salvage surgery and radiation (RT) are the ... See full document
16
Sarcoma: Olaratumab - really a breakthrough for soft-tissue sarcomas?
... progression occurred in spite of the combination regimen being more toxic, with a higher incidence of grade ≥3 adverse effects (80% versus 69%), including bone marrow toxicity, nausea, cardiac dysfunction, and decreased ... See full document
7
Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
... Given the heterogenous nature of STS with differing tumour biologies, sensitivity to RT and chemotherapy and metastatic potential, the belief that adjuvant chemo- therapy is effective for all STSs is an ineffectual ... See full document
78
Treatment patterns and survival among older adults in the United States with advanced soft-tissue sarcomas
... systemic treatment, up to five lines of treatment were ...First-line treatment was examined among all patients, with at least one claim for an HCPCS-identifiable chemotherapeutic, biologic, or ... See full document
14
Supervised Machine-Learning Enables Segmentation and Evaluation of Heterogeneous Post-treatment Changes in Multi-Parametric MRI of Soft-Tissue Sarcoma.
... variable tissue components that include cellular tumor, fat, necrosis, and cystic ...assessing treatment response are limited as responding tumors may not change in size, or may even grow ... See full document
15
Trabectedin for advanced soft tissue sarcomas: optimizing use
... The first Phase II studies were conducted in 1999, and since then more than 1,000 patients have received trabectedin in the context of clinical trials, compassionate use programs, expanded access programs, or in standard ... See full document
5
Misdiagnosis of soft tissue sarcomas of the lower limb associated with deep venous thrombosis: report of two cases and review of the literature
... The incidence of soft tissue sarcomas (STSs) is approxi- mately 15-35 cases per million person-years, accounting for less than 1% of all malignancies [1-3]. About 3,200 new cases of STSs are ... See full document
13
A Study on Limb Salvage in Extremity Soft Tissue Sarcomas
... distally. It includes excision of some overlying skin to encompass all previous scars or biopsy sites. Tumour should not be visualized during the excision so tumour cells are not spilled into the surgical bed. On the ... See full document
Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas.
... and Treatment of Cancer 30-item core QoL questionnaire (EORTC QLQ-C30) [7] is widely used, for example by Quinten and colleagues [3 − 5], to demonstrate the prognostic value of HRQoL domain ...with soft ... See full document
44
Related subjects